Reply to “The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery”

A. MacrìDepartment of Human Pathology, University of Messina, Messina, Italy and Correspondence[email protected]

F. FleresDepartment of Human Pathology, University of Messina, Messina, Italy and

E. CucinottaDepartment of Human Pathology, University of Messina, Messina, Italy and

R. CatanosoS.A.S.T.A.S. Department, University of Messina, Messina, Italy

E. SaladinoDepartment of Human Pathology, University of Messina, Messina, Italy and

References

Macrì A, Arcoraci V, Belgrano V, et al. Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Preliminary analysis of a multicentre study. Anticancer Res. 2014;34(10):5689–5693
PubMedGoogle Scholar
Stewart JH IV, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy: An evolving paradigm for the treatment of peritoneal surface malignancies. Expert Rev Anticancer Ther. 2008;8:1809–1818
PubMed Web of Science ®Google Scholar
Kusamura S, Younan R, Baratti D, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144–1153
PubMed Web of Science ®Google Scholar
Kusamura S, Baratti D, Deraco M. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg. 2012;255:348–356
PubMed Web of Science ®Google Scholar
Feldman L, Barkun J, Barkun A, Sampalis J, Rosenberg L. Measuring postoperative complications in general surgery patients using an outcomes-based strategy: Comparison with complications presented at morbidity and mortality rounds. Surgery. 1997;122:711–719
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Reply to “The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery”

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Reply to “The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery”

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date